Effectiveness of a hybrid approach in integrating GLP-1 agonists and lifestyle guidance for obesity and pre-diabetes management: RWE retrospective study
Similar content being viewed by others Introduction Brain-derived neurotrophic factor (BDNF) is a neurotrophin family member mainly expressed in the brain, in both the hippocampus and cortex, but also present at the peripheral level 1
Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1RA) class type 2 diabetes treatment, to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, progression to kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD)
It also supports the manufacture of creatine, an energy substrate for muscles
Safety depends on the specific peptide, product quality, dose, health history, lab monitoring, and provider oversight